Aviva’s MyoKardia MYOK Stock Holding History
Bought
Maintained
Sold
Aviva's MYOK Position: Q4 2020 in Review
Aviva sold out of MyoKardia (MYOK) in Q4 2020, closing a stake of 17,197 shares — an estimated $2.34M sold.
Aviva first reported a position in MYOK in Q4 2019 and held it in 4 quarters. The position peaked at $3.29M in Q1 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.
- Aviva reported no remaining MyoKardia position as of Q4 2020 after selling out during the quarter.
- Aviva sold 17,197 MyoKardia shares in Q4 2020, an estimated $2.34M.
- Aviva first reported a position in MyoKardia in Q4 2019 and held it in 4 quarters.
- Aviva's MyoKardia position peaked at $3.29M in Q1 2020.
- 0 funds tracked by Wall St. Rank held MyoKardia as of Q4 2020.
Based on Aviva's 13F filing for Q4 2020, filed 10 Feb 2021.